Shreyas Intermed Peer Comparison

BSE: 526335

₹6.58

₹-0.43 (-6.13%)

As on 18-Sep-2026IST

Market cap

₹47 Cr

Revenue (TTM)

₹10 Cr

P/E Ratio

--

P/B Ratio

4.2

Div. Yield

0 %

Edit

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Market cap (₹ Cr)	47	10,038	4,825	3,465	2,399
Revenue (₹ Cr)	10	9,922	939	950	2,267
Net Profit (₹ Cr)	-1.07	53.80	57.67	5,700.75	68.67
Net Margin (%)	-9.83	0.54	6.13	413.96	2.97
RoE (%)	-6.92	3.01	13.23	19.46	6.03
Price to Earnings	--	138.65	83.68	0.59	34.93
Price-To-Book	4.25	2.78	10.05	0.51	2.02

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Operating Revenue	10.37	9,922.40	939.14	949.88	2,267.08
Total Income	10.88	10,032.40	941.36	1,377.14	2,310.83
Total Expenditure	10.47	9,303.70	755.18	1,138.68	2,084.54
EBITDA	-0.10	618.70	183.96	-188.80	182.54
Depreciation	1.48	341.30	55.75	47.28	69.53
EBIT	-1.58	277.40	128.21	-236.07	113.02
Interest	0.00	161.30	53.24	137.07	75.76
Other Income	0.51	110.00	2.22	427.26	43.75
Exceptional Items	0.00	-29.70	0.00	5,881.23	-0.03
Profit before Tax	-1.07	196.40	77.19	5,935.34	80.98
Provision for Tax	0.00	142.60	19.53	234.60	12.30
Profit after Tax	-1.07	53.80	57.67	5,700.75	68.67

Liabilities (₹ Cr)

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Shareholder's Funds	15.12	3,450.20	443.92	6,436.35	1,157.54
Minority Interest	0.00	-16.80	0.00	-0.90	0.00
Non-Current Liabilities	7.74	2,971.80	347.18	55.14	436.68
Current Liabilities	2.08	2,897.50	363.97	538.62	761.56
Total Liabilities	26.61	10,040.44	1,094.15	4,725.22	2,339.32

Assets (₹ Cr)

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Non-Current Assets	15.68	2,830.80	629.11	1,730.17	1,314.76
Current Assets	9.26	5,964.40	498.57	4,697.70	934.39
Total Assets	26.61	10,040.44	1,094.15	4,725.22	2,339.32
Total Debt*	7.74	2,084.70	567.81	1,122.95	905.97
Net Current Assets	7.18	3,066.90	134.60	4,159.08	172.84
Contingent Liabilities	4.97	200.50	55.48	1,493.81	54.78

Cashflow (₹ Cr)

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Cash From Operating Activities	1.35	71.30	-40.85	-341.93	113.78
Cash Flow from Investing Activities	-1.35	-1,582.90	-8.75	-842.32	-37.01
Cash from Financing Activities	--	2,596.10	58.10	1,193.74	-73.46
Net Cash Inflow / Outflow	0.00	1,084.50	8.50	9.49	3.32

Ratios

Profitability Ratios

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
ROCE (%)	-6.31	4.24	7.54	10.72	5.06
ROE (%)	-6.92	3.01	13.23	19.46	6.03
ROA (%)	-4.15	0.55	5.13	96.92	2.92
EBIT Margin (%)	-15.24	2.80	13.65	-24.85	4.99
Net Margin (%)	-9.83	0.54	6.13	413.96	2.97
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Revenue Growth (%)	64.08	90.13	34.20	25.19	27.32
EBIT Growth (%)	22.17	5.24	70.97	-104.47	6.09
Net Profit Growth (%)	29.14	-29.02	372.25	3,691.41	135.10
EPS Growth (%)	29.14	79.91	364.49	353.43	128.73
Book Value Growth (%)	-11.34	194.04	42.41	10.13	2.17

Valuation Ratios

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Price / Earnings	-43.57	94.45	83.68	3.46	34.91
Price / Book Value	4.25	2.78	10.05	0.51	2.02
Dividend Yield (%)	0.00	0.40	0.01	0.00	0.00
EV/EBITDA	-543.09	17.39	29.12	3.21	17.41
Market Cap (₹ Cr)	--	7,783.20	2,068.61	3,475.16	737.31

Solvency Ratios

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Debt to Equity	0.51	0.48	0.65	0.00	0.29
Short term debt to equity ratio	--	0.11	0.53	0.00	0.35
Current Ratio	4.45	2.06	1.37	8.72	1.23
Quick Ratio	4.44	1.22	0.67	8.41	0.80
Interest Coverage	-118.21	2.22	2.45	44.30	2.07

Operating Efficiency Ratios

	Shreyas Intermed	Sudarshan Chemical	Yasho	Kiri	Bodal Chemicals
Debtors to sales (%)	24.69	16.92	19.29	10.95	19.35
Asset Turnover	0.40	1.02	0.84	0.16	0.96
Receivable days	--	98.75	67.79	48.19	81.07
Inventory Days	--	160.34	106.54	68.40	62.85
Payable days	--	196.09	52.82	216.35	88.92
Cash Conversion Cycle	--	63.01	121.52	-99.76	55.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly